nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—Carbamazepine—epilepsy syndrome	0.254	0.52	CrCtD
Nepafenac—Oxcarbazepine—epilepsy syndrome	0.234	0.48	CrCtD
Nepafenac—PTGS2—epilepsy syndrome	0.106	1	CbGaD
Nepafenac—Phenacemide—Felbamate—epilepsy syndrome	0.0299	0.104	CrCrCtD
Nepafenac—PTGS1—Diazepam—epilepsy syndrome	0.029	0.559	CbGbCtD
Nepafenac—Magnesium salicylate—Carbamazepine—epilepsy syndrome	0.028	0.0972	CrCrCtD
Nepafenac—Magnesium salicylate—Oxcarbazepine—epilepsy syndrome	0.0258	0.0896	CrCrCtD
Nepafenac—PTGS1—Valproic Acid—epilepsy syndrome	0.0228	0.441	CbGbCtD
Nepafenac—Modafinil—Fosphenytoin—epilepsy syndrome	0.0188	0.0653	CrCrCtD
Nepafenac—Carbamazepine—Phenytoin—epilepsy syndrome	0.0187	0.0649	CrCrCtD
Nepafenac—Phenacemide—Lacosamide—epilepsy syndrome	0.0172	0.0595	CrCrCtD
Nepafenac—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.0159	0.0552	CrCrCtD
Nepafenac—Salsalate—Carbamazepine—epilepsy syndrome	0.0147	0.0508	CrCrCtD
Nepafenac—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.0147	0.0508	CrCrCtD
Nepafenac—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0135	0.0468	CrCrCtD
Nepafenac—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0131	0.0455	CrCrCtD
Nepafenac—Oxcarbazepine—Clobazam—epilepsy syndrome	0.013	0.0449	CrCrCtD
Nepafenac—Modafinil—Phenytoin—epilepsy syndrome	0.0129	0.0447	CrCrCtD
Nepafenac—Oxcarbazepine—Diazepam—epilepsy syndrome	0.012	0.0417	CrCrCtD
Nepafenac—Modafinil—Carbamazepine—epilepsy syndrome	0.0119	0.0413	CrCrCtD
Nepafenac—Modafinil—Oxcarbazepine—epilepsy syndrome	0.011	0.038	CrCrCtD
Nepafenac—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.00899	0.0312	CrCrCtD
Nepafenac—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0083	0.0288	CrCrCtD
Nepafenac—Phenacemide—SCN1A—epilepsy syndrome	0.000289	0.13	CrCbGaD
Nepafenac—Diclofenac—KCNQ3—epilepsy syndrome	0.000268	0.12	CrCbGaD
Nepafenac—Diclofenac—KCNQ2—epilepsy syndrome	0.000268	0.12	CrCbGaD
Nepafenac—Diclofenac—SCN4A—epilepsy syndrome	0.000162	0.073	CrCbGaD
Nepafenac—Carbamazepine—SCN9A—epilepsy syndrome	0.000152	0.0681	CrCbGaD
Nepafenac—Carbamazepine—SCN4A—epilepsy syndrome	0.000139	0.0626	CrCbGaD
Nepafenac—Dry eye—Topiramate—epilepsy syndrome	0.00013	0.00242	CcSEcCtD
Nepafenac—Nausea—Amobarbital—epilepsy syndrome	0.00013	0.00241	CcSEcCtD
Nepafenac—Eye disorder—Oxcarbazepine—epilepsy syndrome	0.000129	0.00239	CcSEcCtD
Nepafenac—Hypertension—Propofol—epilepsy syndrome	0.000128	0.00238	CcSEcCtD
Nepafenac—Vision blurred—Vigabatrin—epilepsy syndrome	0.000127	0.00236	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000126	0.00235	CcSEcCtD
Nepafenac—Immune system disorder—Clonazepam—epilepsy syndrome	0.000126	0.00234	CcSEcCtD
Nepafenac—Vision blurred—Diazepam—epilepsy syndrome	0.000125	0.00233	CcSEcCtD
Nepafenac—Arthritis—Gabapentin—epilepsy syndrome	0.000125	0.00232	CcSEcCtD
Nepafenac—Immune system disorder—Phenytoin—epilepsy syndrome	0.000125	0.00232	CcSEcCtD
Nepafenac—Angiopathy—Oxcarbazepine—epilepsy syndrome	0.000125	0.00232	CcSEcCtD
Nepafenac—Nausea—Primidone—epilepsy syndrome	0.000125	0.00232	CcSEcCtD
Nepafenac—Immune system disorder—Oxcarbazepine—epilepsy syndrome	0.000124	0.00231	CcSEcCtD
Nepafenac—Dry mouth—Propofol—epilepsy syndrome	0.000124	0.0023	CcSEcCtD
Nepafenac—Eye disorder—Carbamazepine—epilepsy syndrome	0.000124	0.00229	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.000123	0.00228	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.000121	0.00225	CcSEcCtD
Nepafenac—Dry mouth—Midazolam—epilepsy syndrome	0.000121	0.00225	CcSEcCtD
Nepafenac—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000121	0.00224	CcSEcCtD
Nepafenac—Angiopathy—Carbamazepine—epilepsy syndrome	0.00012	0.00223	CcSEcCtD
Nepafenac—Hypertension—Fosphenytoin—epilepsy syndrome	0.00012	0.00222	CcSEcCtD
Nepafenac—Immune system disorder—Carbamazepine—epilepsy syndrome	0.000119	0.00222	CcSEcCtD
Nepafenac—Eye disorder—Lamotrigine—epilepsy syndrome	0.000119	0.00222	CcSEcCtD
Nepafenac—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000118	0.0022	CcSEcCtD
Nepafenac—Diabetes mellitus—Topiramate—epilepsy syndrome	0.000118	0.00218	CcSEcCtD
Nepafenac—Vomiting—Trimethadione—epilepsy syndrome	0.000118	0.00218	CcSEcCtD
Nepafenac—Nervous system disorder—Midazolam—epilepsy syndrome	0.000116	0.00216	CcSEcCtD
Nepafenac—Angiopathy—Lamotrigine—epilepsy syndrome	0.000116	0.00215	CcSEcCtD
Nepafenac—Headache—Trimethadione—epilepsy syndrome	0.000116	0.00215	CcSEcCtD
Nepafenac—Dry mouth—Fosphenytoin—epilepsy syndrome	0.000115	0.00214	CcSEcCtD
Nepafenac—Skin disorder—Midazolam—epilepsy syndrome	0.000115	0.00214	CcSEcCtD
Nepafenac—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000115	0.00213	CcSEcCtD
Nepafenac—Vision blurred—Clonazepam—epilepsy syndrome	0.000114	0.00212	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.000114	0.00212	CcSEcCtD
Nepafenac—Skin disorder—Levetiracetam—epilepsy syndrome	0.000114	0.00211	CcSEcCtD
Nepafenac—Pruritus—Rufinamide—epilepsy syndrome	0.000114	0.00211	CcSEcCtD
Nepafenac—Eye pain—Topiramate—epilepsy syndrome	0.000113	0.00211	CcSEcCtD
Nepafenac—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000113	0.0021	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000113	0.00209	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.000112	0.00209	CcSEcCtD
Nepafenac—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000111	0.00206	CcSEcCtD
Nepafenac—Hypertension—Felbamate—epilepsy syndrome	0.000111	0.00206	CcSEcCtD
Nepafenac—Dry mouth—Diazepam—epilepsy syndrome	0.000111	0.00206	CcSEcCtD
Nepafenac—Nausea—Trimethadione—epilepsy syndrome	0.00011	0.00204	CcSEcCtD
Nepafenac—Hypertension—Zonisamide—epilepsy syndrome	0.000109	0.00202	CcSEcCtD
Nepafenac—Vision blurred—Carbamazepine—epilepsy syndrome	0.000109	0.00201	CcSEcCtD
Nepafenac—Dizziness—Phenobarbital—epilepsy syndrome	0.000108	0.00201	CcSEcCtD
Nepafenac—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000108	0.00201	CcSEcCtD
Nepafenac—Dry mouth—Felbamate—epilepsy syndrome	0.000107	0.00199	CcSEcCtD
Nepafenac—Skin disorder—Vigabatrin—epilepsy syndrome	0.000107	0.00199	CcSEcCtD
Nepafenac—Pruritus—Lacosamide—epilepsy syndrome	0.000107	0.00198	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000107	0.00198	CcSEcCtD
Nepafenac—Nervous system disorder—Diazepam—epilepsy syndrome	0.000106	0.00198	CcSEcCtD
Nepafenac—Dizziness—Rufinamide—epilepsy syndrome	0.000106	0.00197	CcSEcCtD
Nepafenac—Sinusitis—Valproic Acid—epilepsy syndrome	0.000106	0.00197	CcSEcCtD
Nepafenac—Skin disorder—Diazepam—epilepsy syndrome	0.000105	0.00196	CcSEcCtD
Nepafenac—Dry mouth—Zonisamide—epilepsy syndrome	0.000105	0.00195	CcSEcCtD
Nepafenac—Vision blurred—Lamotrigine—epilepsy syndrome	0.000105	0.00195	CcSEcCtD
Nepafenac—Vomiting—Phenobarbital—epilepsy syndrome	0.000104	0.00193	CcSEcCtD
Nepafenac—Hypertension—Phenytoin—epilepsy syndrome	0.000104	0.00193	CcSEcCtD
Nepafenac—Pruritus—Clobazam—epilepsy syndrome	0.000104	0.00192	CcSEcCtD
Nepafenac—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000104	0.00192	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.000103	0.00191	CcSEcCtD
Nepafenac—Headache—Phenobarbital—epilepsy syndrome	0.000103	0.0019	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000102	0.0019	CcSEcCtD
Nepafenac—Vomiting—Rufinamide—epilepsy syndrome	0.000102	0.0019	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000101	0.00188	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000101	0.00188	CcSEcCtD
Nepafenac—Dry mouth—Clonazepam—epilepsy syndrome	0.000101	0.00188	CcSEcCtD
Nepafenac—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000101	0.00187	CcSEcCtD
Nepafenac—Headache—Rufinamide—epilepsy syndrome	0.000101	0.00187	CcSEcCtD
Nepafenac—Dry mouth—Phenytoin—epilepsy syndrome	0.0001	0.00186	CcSEcCtD
Nepafenac—Dry mouth—Oxcarbazepine—epilepsy syndrome	9.99e-05	0.00185	CcSEcCtD
Nepafenac—Skin disorder—Zonisamide—epilepsy syndrome	9.99e-05	0.00185	CcSEcCtD
Nepafenac—Dizziness—Lacosamide—epilepsy syndrome	9.98e-05	0.00185	CcSEcCtD
Nepafenac—Hypertension—Carbamazepine—epilepsy syndrome	9.94e-05	0.00184	CcSEcCtD
Nepafenac—Ketoprofen—SLCO1A2—epilepsy syndrome	9.93e-05	0.0446	CrCbGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	9.73e-05	0.00181	CcSEcCtD
Nepafenac—Nausea—Phenobarbital—epilepsy syndrome	9.73e-05	0.00181	CcSEcCtD
Nepafenac—Nervous system disorder—Clonazepam—epilepsy syndrome	9.72e-05	0.0018	CcSEcCtD
Nepafenac—Dizziness—Clobazam—epilepsy syndrome	9.69e-05	0.0018	CcSEcCtD
Nepafenac—Nervous system disorder—Phenytoin—epilepsy syndrome	9.65e-05	0.00179	CcSEcCtD
Nepafenac—Skin disorder—Clonazepam—epilepsy syndrome	9.63e-05	0.00179	CcSEcCtD
Nepafenac—Hypertension—Lamotrigine—epilepsy syndrome	9.61e-05	0.00178	CcSEcCtD
Nepafenac—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	9.6e-05	0.00178	CcSEcCtD
Nepafenac—Vomiting—Lacosamide—epilepsy syndrome	9.6e-05	0.00178	CcSEcCtD
Nepafenac—Sinusitis—Pregabalin—epilepsy syndrome	9.6e-05	0.00178	CcSEcCtD
Nepafenac—Dry mouth—Carbamazepine—epilepsy syndrome	9.59e-05	0.00178	CcSEcCtD
Nepafenac—Nausea—Rufinamide—epilepsy syndrome	9.55e-05	0.00177	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	9.52e-05	0.00177	CcSEcCtD
Nepafenac—Skin disorder—Oxcarbazepine—epilepsy syndrome	9.51e-05	0.00177	CcSEcCtD
Nepafenac—Eye disorder—Valproic Acid—epilepsy syndrome	9.49e-05	0.00176	CcSEcCtD
Nepafenac—Headache—Lacosamide—epilepsy syndrome	9.46e-05	0.00176	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Diazepam—epilepsy syndrome	9.37e-05	0.00174	CcSEcCtD
Nepafenac—Vomiting—Clobazam—epilepsy syndrome	9.32e-05	0.00173	CcSEcCtD
Nepafenac—Dry mouth—Lamotrigine—epilepsy syndrome	9.26e-05	0.00172	CcSEcCtD
Nepafenac—Angiopathy—Valproic Acid—epilepsy syndrome	9.22e-05	0.00171	CcSEcCtD
Nepafenac—Nervous system disorder—Carbamazepine—epilepsy syndrome	9.21e-05	0.00171	CcSEcCtD
Nepafenac—Headache—Clobazam—epilepsy syndrome	9.18e-05	0.0017	CcSEcCtD
Nepafenac—Immune system disorder—Valproic Acid—epilepsy syndrome	9.17e-05	0.0017	CcSEcCtD
Nepafenac—Skin disorder—Carbamazepine—epilepsy syndrome	9.13e-05	0.00169	CcSEcCtD
Nepafenac—Nausea—Lacosamide—epilepsy syndrome	8.97e-05	0.00166	CcSEcCtD
Nepafenac—Nervous system disorder—Lamotrigine—epilepsy syndrome	8.91e-05	0.00165	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	8.88e-05	0.00165	CcSEcCtD
Nepafenac—Sinusitis—Gabapentin—epilepsy syndrome	8.8e-05	0.00163	CcSEcCtD
Nepafenac—Hypersensitivity—Midazolam—epilepsy syndrome	8.74e-05	0.00162	CcSEcCtD
Nepafenac—Nausea—Clobazam—epilepsy syndrome	8.7e-05	0.00162	CcSEcCtD
Nepafenac—Dizziness—Acetazolamide—epilepsy syndrome	8.64e-05	0.0016	CcSEcCtD
Nepafenac—Hypersensitivity—Levetiracetam—epilepsy syndrome	8.63e-05	0.0016	CcSEcCtD
Nepafenac—Pruritus—Propofol—epilepsy syndrome	8.58e-05	0.00159	CcSEcCtD
Nepafenac—Eye disorder—Pregabalin—epilepsy syndrome	8.58e-05	0.00159	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	8.56e-05	0.00159	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	8.5e-05	0.00158	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	8.45e-05	0.00157	CcSEcCtD
Nepafenac—Pruritus—Midazolam—epilepsy syndrome	8.4e-05	0.00156	CcSEcCtD
Nepafenac—Vision blurred—Valproic Acid—epilepsy syndrome	8.33e-05	0.00155	CcSEcCtD
Nepafenac—Angiopathy—Pregabalin—epilepsy syndrome	8.33e-05	0.00155	CcSEcCtD
Nepafenac—Vomiting—Acetazolamide—epilepsy syndrome	8.3e-05	0.00154	CcSEcCtD
Nepafenac—Immune system disorder—Pregabalin—epilepsy syndrome	8.29e-05	0.00154	CcSEcCtD
Nepafenac—Pruritus—Levetiracetam—epilepsy syndrome	8.29e-05	0.00154	CcSEcCtD
Nepafenac—Headache—Acetazolamide—epilepsy syndrome	8.18e-05	0.00152	CcSEcCtD
Nepafenac—Hypersensitivity—Vigabatrin—epilepsy syndrome	8.12e-05	0.00151	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	8.11e-05	0.00151	CcSEcCtD
Nepafenac—Dizziness—Propofol—epilepsy syndrome	8.02e-05	0.00149	CcSEcCtD
Nepafenac—Pruritus—Fosphenytoin—epilepsy syndrome	8e-05	0.00149	CcSEcCtD
Nepafenac—Hypersensitivity—Diazepam—epilepsy syndrome	8e-05	0.00148	CcSEcCtD
Nepafenac—Eye disorder—Gabapentin—epilepsy syndrome	7.87e-05	0.00146	CcSEcCtD
Nepafenac—Dizziness—Midazolam—epilepsy syndrome	7.85e-05	0.00146	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	7.84e-05	0.00146	CcSEcCtD
Nepafenac—Pruritus—Vigabatrin—epilepsy syndrome	7.8e-05	0.00145	CcSEcCtD
Nepafenac—Nausea—Acetazolamide—epilepsy syndrome	7.76e-05	0.00144	CcSEcCtD
Nepafenac—Dizziness—Levetiracetam—epilepsy syndrome	7.75e-05	0.00144	CcSEcCtD
Nepafenac—Vomiting—Propofol—epilepsy syndrome	7.71e-05	0.00143	CcSEcCtD
Nepafenac—Pruritus—Diazepam—epilepsy syndrome	7.68e-05	0.00143	CcSEcCtD
Nepafenac—Hypertension—Valproic Acid—epilepsy syndrome	7.63e-05	0.00142	CcSEcCtD
Nepafenac—Immune system disorder—Gabapentin—epilepsy syndrome	7.61e-05	0.00141	CcSEcCtD
Nepafenac—Headache—Propofol—epilepsy syndrome	7.6e-05	0.00141	CcSEcCtD
Nepafenac—Hypersensitivity—Zonisamide—epilepsy syndrome	7.58e-05	0.00141	CcSEcCtD
Nepafenac—Vomiting—Midazolam—epilepsy syndrome	7.55e-05	0.0014	CcSEcCtD
Nepafenac—Vision blurred—Pregabalin—epilepsy syndrome	7.53e-05	0.0014	CcSEcCtD
Nepafenac—Dizziness—Fosphenytoin—epilepsy syndrome	7.48e-05	0.00139	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	7.48e-05	0.00139	CcSEcCtD
Nepafenac—Vomiting—Levetiracetam—epilepsy syndrome	7.45e-05	0.00138	CcSEcCtD
Nepafenac—Headache—Midazolam—epilepsy syndrome	7.43e-05	0.00138	CcSEcCtD
Nepafenac—Pruritus—Felbamate—epilepsy syndrome	7.43e-05	0.00138	CcSEcCtD
Nepafenac—Sinusitis—Topiramate—epilepsy syndrome	7.4e-05	0.00137	CcSEcCtD
Nepafenac—Dry mouth—Valproic Acid—epilepsy syndrome	7.36e-05	0.00137	CcSEcCtD
Nepafenac—Headache—Levetiracetam—epilepsy syndrome	7.34e-05	0.00136	CcSEcCtD
Nepafenac—Hypersensitivity—Clonazepam—epilepsy syndrome	7.3e-05	0.00136	CcSEcCtD
Nepafenac—Dizziness—Vigabatrin—epilepsy syndrome	7.29e-05	0.00135	CcSEcCtD
Nepafenac—Pruritus—Zonisamide—epilepsy syndrome	7.28e-05	0.00135	CcSEcCtD
Nepafenac—Hypersensitivity—Phenytoin—epilepsy syndrome	7.25e-05	0.00135	CcSEcCtD
Nepafenac—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.21e-05	0.00134	CcSEcCtD
Nepafenac—Nausea—Propofol—epilepsy syndrome	7.2e-05	0.00134	CcSEcCtD
Nepafenac—Vomiting—Fosphenytoin—epilepsy syndrome	7.19e-05	0.00133	CcSEcCtD
Nepafenac—Dizziness—Diazepam—epilepsy syndrome	7.18e-05	0.00133	CcSEcCtD
Nepafenac—Headache—Fosphenytoin—epilepsy syndrome	7.09e-05	0.00131	CcSEcCtD
Nepafenac—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.08e-05	0.00131	CcSEcCtD
Nepafenac—Nausea—Midazolam—epilepsy syndrome	7.05e-05	0.00131	CcSEcCtD
Nepafenac—Pruritus—Clonazepam—epilepsy syndrome	7.01e-05	0.0013	CcSEcCtD
Nepafenac—Vomiting—Vigabatrin—epilepsy syndrome	7.01e-05	0.0013	CcSEcCtD
Nepafenac—Skin disorder—Valproic Acid—epilepsy syndrome	7.01e-05	0.0013	CcSEcCtD
Nepafenac—Pruritus—Phenytoin—epilepsy syndrome	6.96e-05	0.00129	CcSEcCtD
Nepafenac—Nausea—Levetiracetam—epilepsy syndrome	6.96e-05	0.00129	CcSEcCtD
Nepafenac—Dizziness—Felbamate—epilepsy syndrome	6.95e-05	0.00129	CcSEcCtD
Nepafenac—Pruritus—Oxcarbazepine—epilepsy syndrome	6.93e-05	0.00129	CcSEcCtD
Nepafenac—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.92e-05	0.00128	CcSEcCtD
Nepafenac—Vision blurred—Gabapentin—epilepsy syndrome	6.91e-05	0.00128	CcSEcCtD
Nepafenac—Headache—Vigabatrin—epilepsy syndrome	6.91e-05	0.00128	CcSEcCtD
Nepafenac—Hypertension—Pregabalin—epilepsy syndrome	6.9e-05	0.00128	CcSEcCtD
Nepafenac—Vomiting—Diazepam—epilepsy syndrome	6.9e-05	0.00128	CcSEcCtD
Nepafenac—Dizziness—Zonisamide—epilepsy syndrome	6.8e-05	0.00126	CcSEcCtD
Nepafenac—Headache—Diazepam—epilepsy syndrome	6.8e-05	0.00126	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.76e-05	0.00125	CcSEcCtD
Nepafenac—Nausea—Fosphenytoin—epilepsy syndrome	6.72e-05	0.00125	CcSEcCtD
Nepafenac—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.69e-05	0.00124	CcSEcCtD
Nepafenac—Vomiting—Felbamate—epilepsy syndrome	6.68e-05	0.00124	CcSEcCtD
Nepafenac—Dry mouth—Pregabalin—epilepsy syndrome	6.66e-05	0.00124	CcSEcCtD
Nepafenac—Pruritus—Carbamazepine—epilepsy syndrome	6.65e-05	0.00123	CcSEcCtD
Nepafenac—Eye disorder—Topiramate—epilepsy syndrome	6.62e-05	0.00123	CcSEcCtD
Nepafenac—Headache—Felbamate—epilepsy syndrome	6.58e-05	0.00122	CcSEcCtD
Nepafenac—Dizziness—Clonazepam—epilepsy syndrome	6.55e-05	0.00122	CcSEcCtD
Nepafenac—Nausea—Vigabatrin—epilepsy syndrome	6.55e-05	0.00122	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—epilepsy syndrome	6.54e-05	0.0294	CrCbGaD
Nepafenac—Vomiting—Zonisamide—epilepsy syndrome	6.54e-05	0.00121	CcSEcCtD
Nepafenac—Dizziness—Phenytoin—epilepsy syndrome	6.51e-05	0.00121	CcSEcCtD
Nepafenac—Dizziness—Oxcarbazepine—epilepsy syndrome	6.48e-05	0.0012	CcSEcCtD
Nepafenac—Nausea—Diazepam—epilepsy syndrome	6.45e-05	0.0012	CcSEcCtD
Nepafenac—Headache—Zonisamide—epilepsy syndrome	6.44e-05	0.0012	CcSEcCtD
Nepafenac—Angiopathy—Topiramate—epilepsy syndrome	6.43e-05	0.00119	CcSEcCtD
Nepafenac—Pruritus—Lamotrigine—epilepsy syndrome	6.42e-05	0.00119	CcSEcCtD
Nepafenac—Immune system disorder—Topiramate—epilepsy syndrome	6.4e-05	0.00119	CcSEcCtD
Nepafenac—Nervous system disorder—Pregabalin—epilepsy syndrome	6.4e-05	0.00119	CcSEcCtD
Nepafenac—Skin disorder—Pregabalin—epilepsy syndrome	6.34e-05	0.00118	CcSEcCtD
Nepafenac—Hypertension—Gabapentin—epilepsy syndrome	6.33e-05	0.00117	CcSEcCtD
Nepafenac—Vomiting—Clonazepam—epilepsy syndrome	6.3e-05	0.00117	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—epilepsy syndrome	6.27e-05	0.0282	CrCbGaD
Nepafenac—Vomiting—Phenytoin—epilepsy syndrome	6.26e-05	0.00116	CcSEcCtD
Nepafenac—Nausea—Felbamate—epilepsy syndrome	6.24e-05	0.00116	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.23e-05	0.00116	CcSEcCtD
Nepafenac—Vomiting—Oxcarbazepine—epilepsy syndrome	6.23e-05	0.00116	CcSEcCtD
Nepafenac—Dizziness—Carbamazepine—epilepsy syndrome	6.21e-05	0.00115	CcSEcCtD
Nepafenac—Headache—Clonazepam—epilepsy syndrome	6.21e-05	0.00115	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.2e-05	0.00115	CcSEcCtD
Nepafenac—Headache—Phenytoin—epilepsy syndrome	6.17e-05	0.00114	CcSEcCtD
Nepafenac—Headache—Oxcarbazepine—epilepsy syndrome	6.13e-05	0.00114	CcSEcCtD
Nepafenac—Nausea—Zonisamide—epilepsy syndrome	6.11e-05	0.00113	CcSEcCtD
Nepafenac—Dry mouth—Gabapentin—epilepsy syndrome	6.1e-05	0.00113	CcSEcCtD
Nepafenac—Dizziness—Lamotrigine—epilepsy syndrome	6.01e-05	0.00111	CcSEcCtD
Nepafenac—Vomiting—Carbamazepine—epilepsy syndrome	5.97e-05	0.00111	CcSEcCtD
Nepafenac—Nausea—Clonazepam—epilepsy syndrome	5.89e-05	0.00109	CcSEcCtD
Nepafenac—Headache—Carbamazepine—epilepsy syndrome	5.89e-05	0.00109	CcSEcCtD
Nepafenac—Nervous system disorder—Gabapentin—epilepsy syndrome	5.87e-05	0.00109	CcSEcCtD
Nepafenac—Nausea—Phenytoin—epilepsy syndrome	5.85e-05	0.00109	CcSEcCtD
Nepafenac—Nausea—Oxcarbazepine—epilepsy syndrome	5.82e-05	0.00108	CcSEcCtD
Nepafenac—Vision blurred—Topiramate—epilepsy syndrome	5.81e-05	0.00108	CcSEcCtD
Nepafenac—Skin disorder—Gabapentin—epilepsy syndrome	5.81e-05	0.00108	CcSEcCtD
Nepafenac—Vomiting—Lamotrigine—epilepsy syndrome	5.77e-05	0.00107	CcSEcCtD
Nepafenac—Headache—Lamotrigine—epilepsy syndrome	5.69e-05	0.00106	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.63e-05	0.00105	CcSEcCtD
Nepafenac—Nausea—Carbamazepine—epilepsy syndrome	5.58e-05	0.00104	CcSEcCtD
Nepafenac—Nausea—Lamotrigine—epilepsy syndrome	5.39e-05	0.001	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—epilepsy syndrome	5.33e-05	0.024	CrCbGaD
Nepafenac—Hypertension—Topiramate—epilepsy syndrome	5.32e-05	0.000988	CcSEcCtD
Nepafenac—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.32e-05	0.000987	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.21e-05	0.000968	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.16e-05	0.000959	CcSEcCtD
Nepafenac—Dry mouth—Topiramate—epilepsy syndrome	5.13e-05	0.000953	CcSEcCtD
Nepafenac—Pruritus—Valproic Acid—epilepsy syndrome	5.11e-05	0.000948	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—epilepsy syndrome	4.96e-05	0.0223	CrCbGaD
Nepafenac—Nervous system disorder—Topiramate—epilepsy syndrome	4.94e-05	0.000916	CcSEcCtD
Nepafenac—Skin disorder—Topiramate—epilepsy syndrome	4.89e-05	0.000907	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—epilepsy syndrome	4.85e-05	0.0218	CrCbGaD
Nepafenac—Hypersensitivity—Pregabalin—epilepsy syndrome	4.81e-05	0.000892	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—AQP4—epilepsy syndrome	4.78e-05	0.00534	CbGpPWpGaD
Nepafenac—Dizziness—Valproic Acid—epilepsy syndrome	4.77e-05	0.000886	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	4.75e-05	0.0053	CbGpPWpGaD
Nepafenac—Oxcarbazepine—CYP2C19—epilepsy syndrome	4.69e-05	0.0211	CrCbGaD
Nepafenac—Pruritus—Pregabalin—epilepsy syndrome	4.62e-05	0.000857	CcSEcCtD
Nepafenac—Carbamazepine—ABCC2—epilepsy syndrome	4.6e-05	0.0207	CrCbGaD
Nepafenac—Vomiting—Valproic Acid—epilepsy syndrome	4.59e-05	0.000852	CcSEcCtD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—epilepsy syndrome	4.52e-05	0.00505	CbGpPWpGaD
Nepafenac—Headache—Valproic Acid—epilepsy syndrome	4.52e-05	0.000839	CcSEcCtD
Nepafenac—PTGS2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	4.5e-05	0.00502	CbGpPWpGaD
Nepafenac—Magnesium salicylate—ALB—epilepsy syndrome	4.42e-05	0.0198	CrCbGaD
Nepafenac—Hypersensitivity—Gabapentin—epilepsy syndrome	4.41e-05	0.000818	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.35e-05	0.000806	CcSEcCtD
Nepafenac—Dizziness—Pregabalin—epilepsy syndrome	4.31e-05	0.000801	CcSEcCtD
Nepafenac—Nausea—Valproic Acid—epilepsy syndrome	4.29e-05	0.000796	CcSEcCtD
Nepafenac—Pruritus—Gabapentin—epilepsy syndrome	4.23e-05	0.000785	CcSEcCtD
Nepafenac—Salsalate—PTGS2—epilepsy syndrome	4.21e-05	0.0189	CrCbGaD
Nepafenac—Vomiting—Pregabalin—epilepsy syndrome	4.15e-05	0.00077	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	4.12e-05	0.0046	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	4.12e-05	0.0046	CbGpPWpGaD
Nepafenac—Headache—Pregabalin—epilepsy syndrome	4.09e-05	0.000758	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—PLAT—epilepsy syndrome	4.09e-05	0.00456	CbGpPWpGaD
Nepafenac—Mebendazole—ABCB1—epilepsy syndrome	4.04e-05	0.0182	CrCbGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CAT—epilepsy syndrome	3.99e-05	0.00445	CbGpPWpGaD
Nepafenac—Dizziness—Gabapentin—epilepsy syndrome	3.96e-05	0.000734	CcSEcCtD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—epilepsy syndrome	3.93e-05	0.00439	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—epilepsy syndrome	3.88e-05	0.00432	CbGpPWpGaD
Nepafenac—Nausea—Pregabalin—epilepsy syndrome	3.88e-05	0.000719	CcSEcCtD
Nepafenac—Vomiting—Gabapentin—epilepsy syndrome	3.8e-05	0.000706	CcSEcCtD
Nepafenac—Headache—Gabapentin—epilepsy syndrome	3.75e-05	0.000696	CcSEcCtD
Nepafenac—Diclofenac—CYP2C19—epilepsy syndrome	3.73e-05	0.0168	CrCbGaD
Nepafenac—Hypersensitivity—Topiramate—epilepsy syndrome	3.71e-05	0.000688	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—epilepsy syndrome	3.69e-05	0.00412	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL2—epilepsy syndrome	3.67e-05	0.00409	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—GPX1—epilepsy syndrome	3.6e-05	0.00402	CbGpPWpGaD
Nepafenac—Pruritus—Topiramate—epilepsy syndrome	3.56e-05	0.000661	CcSEcCtD
Nepafenac—Nausea—Gabapentin—epilepsy syndrome	3.55e-05	0.000659	CcSEcCtD
Nepafenac—PTGS1—Biological oxidations—CYP2C19—epilepsy syndrome	3.54e-05	0.00395	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP11A1—epilepsy syndrome	3.52e-05	0.00393	CbGpPWpGaD
Nepafenac—Modafinil—CYP2C19—epilepsy syndrome	3.5e-05	0.0158	CrCbGaD
Nepafenac—Fenoprofen—PTGS2—epilepsy syndrome	3.48e-05	0.0157	CrCbGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.34e-05	0.00372	CbGpPWpGaD
Nepafenac—Dizziness—Topiramate—epilepsy syndrome	3.33e-05	0.000618	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—epilepsy syndrome	3.32e-05	0.00371	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCR2—epilepsy syndrome	3.32e-05	0.0037	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	3.27e-05	0.00365	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	3.27e-05	0.00365	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—epilepsy syndrome	3.23e-05	0.0145	CrCbGaD
Nepafenac—Vomiting—Topiramate—epilepsy syndrome	3.2e-05	0.000594	CcSEcCtD
Nepafenac—Carbamazepine—CYP2C19—epilepsy syndrome	3.2e-05	0.0144	CrCbGaD
Nepafenac—PTGS1—Biological oxidations—CYP2D6—epilepsy syndrome	3.18e-05	0.00354	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—epilepsy syndrome	3.18e-05	0.00354	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—epilepsy syndrome	3.16e-05	0.00353	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CAT—epilepsy syndrome	3.16e-05	0.00353	CbGpPWpGaD
Nepafenac—Headache—Topiramate—epilepsy syndrome	3.15e-05	0.000585	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.12e-05	0.00349	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—HES1—epilepsy syndrome	3.12e-05	0.00348	CbGpPWpGaD
Nepafenac—Fenoprofen—ALB—epilepsy syndrome	3.1e-05	0.0139	CrCbGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	3.06e-05	0.00341	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	3.06e-05	0.00341	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS1—epilepsy syndrome	3.04e-05	0.00339	CbGpPWpGaD
Nepafenac—Nausea—Topiramate—epilepsy syndrome	2.99e-05	0.000555	CcSEcCtD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.93e-05	0.00327	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	2.91e-05	0.00325	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—APEX1—epilepsy syndrome	2.88e-05	0.00321	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—GPX1—epilepsy syndrome	2.86e-05	0.00319	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.86e-05	0.00319	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.75e-05	0.00307	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—epilepsy syndrome	2.6e-05	0.0029	CbGpPWpGaD
Nepafenac—Oxcarbazepine—ALB—epilepsy syndrome	2.6e-05	0.0117	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDC42—epilepsy syndrome	2.6e-05	0.0029	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—epilepsy syndrome	2.51e-05	0.0028	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.5e-05	0.00279	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.48e-05	0.00277	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—BDNF—epilepsy syndrome	2.47e-05	0.00276	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—epilepsy syndrome	2.46e-05	0.00274	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—epilepsy syndrome	2.43e-05	0.00271	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CA13—epilepsy syndrome	2.42e-05	0.0027	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—epilepsy syndrome	2.39e-05	0.00266	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—epilepsy syndrome	2.32e-05	0.0104	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	2.29e-05	0.00255	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.27e-05	0.00253	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.23e-05	0.00249	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—RELA—epilepsy syndrome	2.18e-05	0.00244	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.18e-05	0.00244	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	2.12e-05	0.00237	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	2.08e-05	0.00232	CbGpPWpGaD
Nepafenac—Diclofenac—ALB—epilepsy syndrome	2.07e-05	0.00929	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—epilepsy syndrome	2.07e-05	0.00231	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS2—epilepsy syndrome	2.06e-05	0.00924	CrCbGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.98e-05	0.00221	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—epilepsy syndrome	1.97e-05	0.0022	CbGpPWpGaD
Nepafenac—Diclofenac—ABCB1—epilepsy syndrome	1.97e-05	0.00887	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.95e-05	0.00218	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	1.93e-05	0.00215	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CA13—epilepsy syndrome	1.92e-05	0.00215	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.91e-05	0.00213	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FAR1—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CERS1—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PDXK—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—L2HGDH—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GLUD1—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADK—epilepsy syndrome	1.84e-05	0.00205	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—epilepsy syndrome	1.83e-05	0.00823	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	1.81e-05	0.00202	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	1.79e-05	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDXK—epilepsy syndrome	1.74e-05	0.00194	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	1.73e-05	0.00193	CbGpPWpGaD
Nepafenac—Carbamazepine—ABCB1—epilepsy syndrome	1.69e-05	0.00761	CrCbGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	1.68e-05	0.00188	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GAMT—epilepsy syndrome	1.68e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NHLRC1—epilepsy syndrome	1.68e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—EPM2A—epilepsy syndrome	1.68e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PNPO—epilepsy syndrome	1.68e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	1.68e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	1.67e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	1.66e-05	0.00185	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	1.63e-05	0.00182	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NHLRC1—epilepsy syndrome	1.59e-05	0.00178	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EPM2A—epilepsy syndrome	1.59e-05	0.00178	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PNPO—epilepsy syndrome	1.59e-05	0.00178	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	1.57e-05	0.00175	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—QDPR—epilepsy syndrome	1.56e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CA4—epilepsy syndrome	1.56e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—POMC—epilepsy syndrome	1.56e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.55e-05	0.00173	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SV2A—epilepsy syndrome	1.48e-05	0.00165	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—COX3—epilepsy syndrome	1.47e-05	0.00164	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	1.46e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PDXK—epilepsy syndrome	1.46e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GLUD1—epilepsy syndrome	1.46e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CERS1—epilepsy syndrome	1.46e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADK—epilepsy syndrome	1.46e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FAR1—epilepsy syndrome	1.46e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.43e-05	0.0016	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—KCNB1—epilepsy syndrome	1.39e-05	0.00155	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PFKL—epilepsy syndrome	1.39e-05	0.00155	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CACNA2D2—epilepsy syndrome	1.39e-05	0.00155	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLCO1A2—epilepsy syndrome	1.39e-05	0.00155	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC6A8—epilepsy syndrome	1.39e-05	0.00155	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.36e-05	0.00152	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.35e-05	0.00151	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	1.33e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—EPM2A—epilepsy syndrome	1.33e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PNPO—epilepsy syndrome	1.33e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GAMT—epilepsy syndrome	1.33e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PFKL—epilepsy syndrome	1.32e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.27e-05	0.00142	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NEU1—epilepsy syndrome	1.27e-05	0.00142	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—UPB1—epilepsy syndrome	1.27e-05	0.00142	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ATIC—epilepsy syndrome	1.27e-05	0.00142	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	1.24e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—QDPR—epilepsy syndrome	1.24e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CA4—epilepsy syndrome	1.24e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	1.24e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	1.22e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STX1B—epilepsy syndrome	1.21e-05	0.00135	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GBE1—epilepsy syndrome	1.18e-05	0.00132	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	1.18e-05	0.00132	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	1.17e-05	0.0013	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COX3—epilepsy syndrome	1.17e-05	0.0013	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.16e-05	0.00129	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.14e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GBE1—epilepsy syndrome	1.12e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP1R3C—epilepsy syndrome	1.12e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CPSF4—epilepsy syndrome	1.12e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ASAH1—epilepsy syndrome	1.11e-05	0.00124	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.11e-05	0.00124	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—KCNB1—epilepsy syndrome	1.1e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	1.1e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	1.1e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	1.1e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PFKL—epilepsy syndrome	1.1e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—STXBP1—epilepsy syndrome	1.08e-05	0.00121	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.08e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.07e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NT5E—epilepsy syndrome	1.05e-05	0.00118	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALAD—epilepsy syndrome	1.05e-05	0.00118	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ATIC—epilepsy syndrome	1.01e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UPB1—epilepsy syndrome	1.01e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NEU1—epilepsy syndrome	1.01e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	1.01e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	1.01e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	9.84e-06	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	9.72e-06	0.00109	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADSL—epilepsy syndrome	9.64e-06	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	9.54e-06	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GLUL—epilepsy syndrome	9.46e-06	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GBE1—epilepsy syndrome	9.39e-06	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	9.39e-06	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ST3GAL3—epilepsy syndrome	9.33e-06	0.00104	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	9.28e-06	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.18e-06	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	8.99e-06	0.001	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ASAH1—epilepsy syndrome	8.83e-06	0.000985	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	8.68e-06	0.000969	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STXBP1—epilepsy syndrome	8.59e-06	0.000958	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AQP1—epilepsy syndrome	8.43e-06	0.000941	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.41e-06	0.000939	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALAD—epilepsy syndrome	8.37e-06	0.000934	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NT5E—epilepsy syndrome	8.37e-06	0.000934	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	8.17e-06	0.000912	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.1e-06	0.000903	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	7.99e-06	0.000891	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	7.99e-06	0.000891	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	7.81e-06	0.000872	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADSL—epilepsy syndrome	7.66e-06	0.000854	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	7.62e-06	0.000851	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CHRM3—epilepsy syndrome	7.62e-06	0.000851	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GLUL—epilepsy syndrome	7.51e-06	0.000838	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	7.37e-06	0.000822	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.33e-06	0.000818	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	7.14e-06	0.000796	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.1e-06	0.000792	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.96e-06	0.000776	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	6.89e-06	0.000769	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EIF2AK2—epilepsy syndrome	6.79e-06	0.000758	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AQP1—epilepsy syndrome	6.69e-06	0.000747	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.43e-06	0.000717	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPIA—epilepsy syndrome	6.29e-06	0.000701	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG2—epilepsy syndrome	6.21e-06	0.000693	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	6.12e-06	0.000683	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	6.06e-06	0.000676	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	6.05e-06	0.000675	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CHRM3—epilepsy syndrome	6.05e-06	0.000675	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	6.02e-06	0.000672	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.98e-06	0.000667	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.64e-06	0.000629	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.52e-06	0.000616	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.45e-06	0.000608	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	5.43e-06	0.000606	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	5.17e-06	0.000577	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BCHE—epilepsy syndrome	5.15e-06	0.000575	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG2—epilepsy syndrome	4.93e-06	0.000551	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	4.91e-06	0.000548	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLCB1—epilepsy syndrome	4.86e-06	0.000542	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TH—epilepsy syndrome	4.84e-06	0.00054	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	4.81e-06	0.000536	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	4.78e-06	0.000533	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.77e-06	0.000532	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.74e-06	0.000529	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A1—epilepsy syndrome	4.66e-06	0.00052	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JUNB—epilepsy syndrome	4.62e-06	0.000516	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS1—epilepsy syndrome	4.59e-06	0.000512	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.55e-06	0.000508	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HBEGF—epilepsy syndrome	4.38e-06	0.000489	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.33e-06	0.000483	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	4.31e-06	0.000481	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT3—epilepsy syndrome	4.3e-06	0.00048	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ADAM10—epilepsy syndrome	4.2e-06	0.000468	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	4.11e-06	0.000458	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BCHE—epilepsy syndrome	4.09e-06	0.000456	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—epilepsy syndrome	4.04e-06	0.000451	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—epilepsy syndrome	3.99e-06	0.000445	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDC42—epilepsy syndrome	3.92e-06	0.000438	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	3.9e-06	0.000435	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCB1—epilepsy syndrome	3.88e-06	0.000433	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLCB1—epilepsy syndrome	3.86e-06	0.00043	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TH—epilepsy syndrome	3.84e-06	0.000429	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—epilepsy syndrome	3.61e-06	0.000402	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HES1—epilepsy syndrome	3.59e-06	0.000401	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FYN—epilepsy syndrome	3.49e-06	0.00039	CbGpPWpGaD
Nepafenac—PTGS2—Disease—H2AFX—epilepsy syndrome	3.48e-06	0.000388	CbGpPWpGaD
Nepafenac—PTGS2—Disease—YWHAZ—epilepsy syndrome	3.36e-06	0.000374	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CCR5—epilepsy syndrome	3.23e-06	0.00036	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—epilepsy syndrome	3.21e-06	0.000358	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—epilepsy syndrome	3.17e-06	0.000353	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGT—epilepsy syndrome	3.16e-06	0.000353	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—epilepsy syndrome	3.1e-06	0.000346	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCB1—epilepsy syndrome	3.08e-06	0.000344	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TSC2—epilepsy syndrome	3e-06	0.000335	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—epilepsy syndrome	2.94e-06	0.000328	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.86e-06	0.000319	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6ST—epilepsy syndrome	2.76e-06	0.000308	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—epilepsy syndrome	2.74e-06	0.000305	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—epilepsy syndrome	2.66e-06	0.000297	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGT—epilepsy syndrome	2.51e-06	0.00028	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—epilepsy syndrome	2.46e-06	0.000274	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—epilepsy syndrome	2.43e-06	0.000271	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF2—epilepsy syndrome	2.23e-06	0.000249	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.12e-06	0.000237	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—epilepsy syndrome	2.11e-06	0.000236	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTOR—epilepsy syndrome	2.03e-06	0.000227	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—epilepsy syndrome	1.93e-06	0.000215	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SRC—epilepsy syndrome	1.63e-06	0.000182	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.07e-06	0.000119	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—epilepsy syndrome	1.01e-06	0.000113	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—epilepsy syndrome	8.47e-07	9.45e-05	CbGpPWpGaD
